PASCAL Trabeculoplasty
Primary Purpose
Open-Angle Glaucoma
Status
Unknown status
Phase
Phase 4
Locations
Mexico
Study Type
Interventional
Intervention
Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
Sponsored by
About this trial
This is an interventional treatment trial for Open-Angle Glaucoma
Eligibility Criteria
Inclusion Criteria:
- 18-year-old patients
- Uncontrolled Open angle (Shaffer IV)
- No previous surgical trabeculoplasty or glaucoma surgery
Exclusion Criteria:
- Patients not willing to participate
- Angle-closure glaucoma
- No clear optical media
Sites / Locations
- Asociación para Evitar la Ceguera en MéxicoRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Group 1
Arm Description
Patients with open-angle glaucoma
Outcomes
Primary Outcome Measures
Intraocular Pressure
Secondary Outcome Measures
Full Information
NCT ID
NCT00804323
First Posted
December 5, 2008
Last Updated
December 6, 2008
Sponsor
Asociación para Evitar la Ceguera en México
1. Study Identification
Unique Protocol Identification Number
NCT00804323
Brief Title
PASCAL Trabeculoplasty
Official Title
Semi-Automated Patterned Laser Trabeculoplasty
Study Type
Interventional
2. Study Status
Record Verification Date
December 2008
Overall Recruitment Status
Unknown status
Study Start Date
December 2007 (undefined)
Primary Completion Date
December 2008 (Anticipated)
Study Completion Date
December 2009 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Asociación para Evitar la Ceguera en México
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP). Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM). Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult. We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Open-Angle Glaucoma
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 1
Arm Type
Experimental
Arm Description
Patients with open-angle glaucoma
Intervention Type
Procedure
Intervention Name(s)
Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
Intervention Description
Pattern Scan Laser trabeculoplasty
Primary Outcome Measure Information:
Title
Intraocular Pressure
Time Frame
During follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-year-old patients
Uncontrolled Open angle (Shaffer IV)
No previous surgical trabeculoplasty or glaucoma surgery
Exclusion Criteria:
Patients not willing to participate
Angle-closure glaucoma
No clear optical media
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Felix Gil Carrasco, MD
Phone
525510841400
Ext
1163
Email
glaucoma_apec@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Felix Gil Carrasco, MD
Organizational Affiliation
Asociación para Evitar la Ceguera en México
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asociación para Evitar la Ceguera en México
City
Mexico
State/Province
DF
ZIP/Postal Code
04030
Country
Mexico
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Felix Gil Carrasco, MD
Phone
525510841400
Ext
1163
Email
glaucoma_apec@hotmail.com
First Name & Middle Initial & Last Name & Degree
Mauricio Turati Acosta, MD
First Name & Middle Initial & Last Name & Degree
Adolfo Morales Gonzalez, MD
12. IPD Sharing Statement
Learn more about this trial
PASCAL Trabeculoplasty
We'll reach out to this number within 24 hrs